MOST POPULAR

Details emerge of first Huntington’s disease gene therapy clinical trial

UniQure announces key details of its planned trial to assess the safety and ability of AMT-130 gene therapy to lower the problematic huntingtin protein...

EIP Pharma Initiates New Study with Neflamapimod for the Treatment of...

EIP Pharma, Inc., a CNS-focused therapeutics company, today announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod as a treatment for...

PEOPLE

LIFE

DESIGN

218,514FansLike
66,788FollowersFollow
25,603SubscribersSubscribe

LATEST VIDEOS

TECH POPULAR

TRAVEL

Swapping Sick for Healthy Brain Cells Slows Huntington’s Disease

Researchers have successfully reduced the symptoms and slowed the progression of Huntington’s disease in mice using healthy human brain cells.  The findings, which were...
0 Condivisioni